Evolutor utilizes its Accelerated Evolution Platform to automate and enhance microbial evolution for biomanufacturing applications. This technology enables the development of highly optimized microbes, addressing the limitations of traditional genetic engineering by unlocking untapped biological potential.
Funding
$420K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional genetic engineering approaches for biomanufacturing have limitations in fully optimizing microbial strains, often failing to unlock the full potential of biological systems for efficient production of desired compounds. This can result in suboptimal yields and increased production costs.
Solution
Evolutor offers an Accelerated Evolution Platform that automates and enhances microbial evolution to develop highly optimized microbes for biomanufacturing applications. By leveraging directed evolution, the platform unlocks untapped biological potential beyond the scope of traditional genetic engineering. This approach allows for the creation of microbial strains with improved performance characteristics, leading to more efficient and cost-effective biomanufacturing processes. The platform harnesses the power of evolution to fine-tune microbes for specific biomanufacturing needs, regardless of whether the underlying mechanisms are fully understood.
Target Audience
The primary target audience includes companies in the biomanufacturing sector seeking to improve the efficiency and cost-effectiveness of their production processes through optimized microbial strains.
Features
- Automated evolution platform for high-throughput microbial strain optimization
- Directed evolution approach to unlock untapped biological potential
- Development of highly-tuned microbes for competitive biomanufacturing
- Ability to optimize microbes without complete understanding of underlying genetic mechanisms